Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07828860 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Start date changed from estimate of Sep 2026 to Sep 17, 2026 · Site details revised at 11 of 11 sites Show 2 more changesShow less
    • Start date changed from estimate of Sep 2026 to Sep 17, 2026
    • Site details revised at 11 of 11 sites
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Safety and Efficacy of Soquelitinib in Adults with Hidradenitis Suppurativa
Trial Details
NCT Number NCT07828860
Lead Sponsor Corvus Pharmaceuticals, Inc.
Conditions Hidradenitis Suppurativa (HS)
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov